Effect of CCR7, CXCR4 and VEGF‑C on the lymph node metastasis of human pancreatic ductal adenocarcinoma

Guo,Jinghui; Lou,Wenhui; Ji,Yuan; Zhang,Shuncai

doi:10.3892/ol.2013.1261

Effect of CCR7, CXCR4 and VEGF‑C on the lymph node metastasis of human pancreatic ductal adenocarcinoma

Authors:
- Jinghui Guo
- Wenhui Lou
- Yuan Ji
- Shuncai Zhang
View Affiliations

Affiliations: Department of Gastroenterology, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, P.R. China, Department of General Surgery, Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China, Department of Pathology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China, Department of Gastroenterology, Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China
Published online on: March 15, 2013 https://doi.org/10.3892/ol.2013.1261
Pages: 1572-1578

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the association between the expression of chemokine receptors CCR7 and CXCR4 and vascular endothelial growth factor (VEGF)‑C and the lymph node metastasis of pancreatic ductal adenocarcinoma (PDAC). The mRNA transcription levels of CCR7, CXCR4 and VEGF‑C were measured in 24 specimens by real‑time reverse transcription (RT)‑PCR, while the protein expression levels were measured in 65 specimens by immuohistochemistry. Professional software for pathological image manipulation (Image Pro Plus 6.0) was used to quantitate the results of the immunohistochemical staining. The mRNA and protein expression levels of CCR7, CXCR4 and VEGF‑C were all significantly higher in the cancer samples compared with those in the adjacent normal tissue. The CCR7 and VEGF‑C mRNA and protein expression levels were significantly higher in the patients with cancer types exhibiting lymph node metastasis and an advanced International Union Against Cancer (UICC) stage (P<0.05). The greater the number of metastatic lymph nodes, the higher the levels of CCR7 expression (P<0.05). There was a significant positive linear correlation between the mRNA and protein expression levels of CCR7 and VEGF‑C (P<0.05). The mRNA and protein expression levels of CXCR4 were not correlated with the lymph node metastasis (P>0.05), however the strong positive expression of CCR7 and VEGF‑C was significantly associated with the lymph node metastasis of PDAC.

View Figures

View References

1	Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM and Farnell MB: Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 247:456–462. 2008. View Article : Google Scholar : PubMed/NCBI
2	House MG, Gönen M, Jarnagin WR, et al: Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg. 11:1549–1555. 2007. View Article : Google Scholar : PubMed/NCBI
3	Arya M, Patel HR and Williamson M: Chemokines: key players in cancer. Curr Med Res Opin. 19:557–564. 2003. View Article : Google Scholar
4	Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S and Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 188:373–386. 1998. View Article : Google Scholar : PubMed/NCBI
5	Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, Robbins PD, Lotze MT and Tahara H: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res. 60:2209–2217. 2000.PubMed/NCBI
6	Murdoch C: CXCR4: chemokine receptor extraordinaire. Immunol Rev. 177:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
7	Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med. 167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
8	Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290–298. 1996.
9	Orlandini M, Marconcini L, Ferruzzi R and Oliviero S: Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA. 93:11675–11680. 1996. View Article : Google Scholar : PubMed/NCBI
10	Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K: Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 92:3566–3570. 1995. View Article : Google Scholar : PubMed/NCBI
11	Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE and Sahin A: CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 11:5686–5693. 2005. View Article : Google Scholar : PubMed/NCBI
12	Günther K, Leier J, Henning G, et al: Predictor of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer. 116:726–733. 2005.PubMed/NCBI
13	Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H and Imamura M: Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 9:3406–3412. 2003.PubMed/NCBI
14	Heresi GA, Wang J, Taichman R, Chirinos JA, Regalado JJ, Lichtstein DM and Rosenblatt JD: Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression. Urol Oncol. 23:261–267. 2005. View Article : Google Scholar
15	Tsuzuki H, Takahashi N, Kojima A, Narita N, Sunaga H, Takabayashi T and Fujieda S: Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. Auris Nasus Larynx. 33:37–42. 2006. View Article : Google Scholar : PubMed/NCBI
16	Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 5:R144–R150. 2003. View Article : Google Scholar : PubMed/NCBI
17	Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M: Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res. 290:289–302. 2003. View Article : Google Scholar : PubMed/NCBI
18	Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W and Hönigschnabl S: Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med. 32:455–460. 2003. View Article : Google Scholar : PubMed/NCBI
19	Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A and Burian M: Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck. 25:464–474. 2003. View Article : Google Scholar : PubMed/NCBI
20	Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T and Uchida Y: Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 97:457–464. 2003. View Article : Google Scholar : PubMed/NCBI
21	Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP and Jacobs IJ: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol. 201:544–554. 2003.PubMed/NCBI
22	Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA and Fox SB: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol. 200:183–194. 2003. View Article : Google Scholar
23	Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009. View Article : Google Scholar : PubMed/NCBI
24	Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W and Tan Y: Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J. 15:519–525. 2009. View Article : Google Scholar : PubMed/NCBI
25	Nakao A, Takeda S, Sakai M, Kaneko T, Inoue S, Sugimoto H and Kanazumi N: Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas. 28:289–292. 2004. View Article : Google Scholar : PubMed/NCBI
26	Büchler MW, Kleeff J and Friess H: Surgical treatment of pancreatic cancer. J Am Coll Surg. 205(4 Suppl): S81–S86. 2007.
27	Koliopanos A, Avgerinos C, Farfaras A, Manes C and Dervenis C: Radical resection of pancreatic cancer. Hepatobiliary Pancreat Dis Int. 7:11–18. 2008.
28	Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001.PubMed/NCBI
29	Nakata B, Fukunaga S, Noda E, Amano R, Yamada N and Hirakawa K: Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology. 74:69–75. 2008. View Article : Google Scholar : PubMed/NCBI
30	Tang RF, Wang SX, Peng L, Wang SX, Zhang M, Li ZF, Zhang ZM, Xiao Y and Zhang FR: Expression of vascular endothelial growth factors A and C in human pancreatic cancer. World J Gastroenterol. 12:280–286. 2006.PubMed/NCBI
31	Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S and Aikou T: Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res. 10:8413–8420. 2004. View Article : Google Scholar
32	Wehler T, Wolfert F, Schimanski CC, Gockel I, Herr W, Biesterfeld S, Seifert JK, Adwan H and Berger MR: Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep. 16:1159–1164. 2006.PubMed/NCBI
33	Niu ZX, Fei LM and Wang CL: Expression of CXCL12-CXCR4 and its association with angiogenesis in pancreatic cancer. Zhonghua Zhong Liu Za Zhi. 31:286–287. 2009.(In Chinese).
34	Neel NF, Schutyser E, Sai J, Fan GH and Richmond A: Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 16:637–658. 2005. View Article : Google Scholar : PubMed/NCBI